Comment on CMS-2026-2212-0001

Summary: Cencora, Inc. argues that pharmaceutical distributors, provider GPOs, and relabelers should not be classified as PBMs or "affiliates" under Section 6224 of the CAA. They contend that these entities perform distinct functions from PBMs and lack the necessary data to comply with the proposed reporting requirements.